The strong correlation between CISD1 and stemness indices underscores its potential role in driving tumor aggressiveness and therapeutic resistance, and high CISD1 expression may serve as an indicator of tumors with enriched cancer stem cell populations, predicting more aggressive disease and reduced therapeutic efficacy. This evidence concerns the gene CISD1 and cancer.